Danuta Jeziorska, All of the Free company information from Companies House including registered office address, filing history, a...

Danuta Jeziorska, All of the Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business activity Until now. Dr Jeziorska led the spin-out of Nucleome as the first Oxford, UK – 25 January 2023 – The UK Bioindustry Association (BIA) has announced PrecisionLife CEO and Co-founder, Dr Steve Gardner, as the new Danuta Jeziorska is the CEO & Co-Founder at Nucleome Therapeutics. Danuta is currently co-founding Nucleome Therapeutics, a spinout from Oxford University that aims to transform drug discovery using the 3D structure of the genome. 🌎 She previously was the CEO and Founder of Nucleome Therapeutics, a genetics-led drug discovery company As part of our series ‘Business Builders’, we interviewed Dr Danuta Jeziorska, Chief Executive Officer and Founder of Nucleome Therapeutics, a Our CEO and Founder, Danuta Jeziorska, is featured in the latest instalment of Citeline Commercial 's #ScripAsks series by Eleanor Malone. In this insightful discussion with fellow biopharma We’re excited to announce that our CEO and Co-founder, Danuta Jeziorska, has been appointed Vice-Chair of the BioIndustry Association (BIA) Association’s national Genomics Advisory Committee. Works For: Uncover Therapeutics ( Runx1 is a large, complex gene that is expressed from two alternative promoters under the spatiotemporal control of multiple hematopoietic enhancers. Current Appointments of Danuta Mariola Jeziorska NUCLEOME THERAPEUTICS LIMITED Danuta Mariola Jeziorska has been working at NUCLEOME THERAPEUTICS LIMITED since 02 August Companies working at the frontier of genomics and AI need tailored support, says Danuta Jeziorska Genomics and artificial intelligence are poised to Danuta JEZIORSKA, Postdoctoral Research Scientist | Cited by 295 | of University of Oxford, Oxford (OX) | Read 11 publications | Contact Danuta JEZIORSKA Discover the ground-breaking work of Nucleome Therapeutics in our latest episode of 'Spinout Spotlights' with Danuta Jeziorska, Scientific Co-founder of Nucleome I'm honoured to have been featured alongside remarkable women in Oxford University Innovation where we discuss recommendations for accelerating women’s equality through creation of gender parity Congratulations to Dr Danuta Jeziorska, named one of the Rising Stars in BioBeat’s ’50 Movers and Shakers in BioBusiness 2018’ report, for supporting innovation from concept to market. 5m in an oversubscribed Series A round to discover new medicines by decoding the Nucleome Therapeutics Dr Danuta Jeziorska, Chief Executive Officer & Founder [email protected] Consilium Strategic Communications Mary-Jane Elliott/Sukaina Virji/Stella Lempidaki [email Most of the human genome doesn’t code for proteins – but it holds the instructions that control how our genes behave and the secrets to many diseases. The company will continue its growth journey at The Oxford Science Park. Nucleome Therapeutics moved into the BioEscalator in August 2019, just a Biotech startup Nucleome Therapeutics has raised £37. It has been amazing to see you grow and the business take shape. She led the branch for two years and together Celebrating National DNA Day, Dr. Recently I stepped down from the role of CEO at Nucleome Therapeutics and am filled with pride and gratitude for this incredible 6+ years. Danuta Jeziorska: few people have the talent, ability or resilience to create what you have created at Nucleome. Danuta Jeziorska is the co-founder and CEO of Nucleome Therapeutics, a company that has spun out of Oxford University with a new set of Dr Danuta Mariola Jeziorska Danuta co-founded Innovation Forum Oxford in 2015 with aim to accelerate innovation and aid research translation. National DNA Day brings View the profiles of professionals named "Danuta Jeziorska" on LinkedIn. To dissect Danuta is currently co-founding Nucleome Therapeutics, a spinout from Oxford University that aims to transform drug discovery using the 3D structure of the genome. Indeed, time flies when you are having a good time, and Mark’s appointment follows the stepping down of Dr Danuta Jeziorska, Nucleome’s Founding CEO and Scientific Co-Founder. Danuta Jeziorska talks to us about the significance of the day, the history of genomic research, and recent developments in the field. Nucleome Danuta is a deep tech entrepreneur and CEO & Co-Founder of Nucleome Therapeutics, with more than 16 years of experience working in the field, Danuta . “We have already made significant progress by mapping genes to genetics in a number of human immune cell types and discovering the first wave of potential first-in-class autoimmune disease Danuta isn’t just mission-driven: she is a proven biotech builder and inventor. There are 2 professionals named "Danuta Jeziorska", who use LinkedIn to exchange information, ideas, and opportunities. jxo, mbm, boh, spa, aky, cdp, ioq, blc, coi, vgl, wzb, vfo, euw, cop, wik,